Preview

South Russian Journal of Cancer

Advanced search

Extraneural metastases of a cerebral glioma in a child: case report with literature review

https://doi.org/10.37748/2686-9039-2024-5-3-10

EDN: PFVHLB

Abstract

Malignant gliomas make up 25 % of the central nervous system (CNS) tumors in adults and 8–15 % in children. About half of such gliomas have a median localization and are designated by the term "diffuse midline gliomas" (DMG). DMG in children are typically localized in the area of the pons; in 78 % of such cases a heterozygous somatic mutation H3K27M is present. The prognosis of H3K27M-mutant DSG is very unfavorable, with 2-year overall survival rate being less than 10 %. One of the ways of progression of gliomas leading to the death of patients is the spread of the tumor in the form of metastases. Malignant gliomas metastasize mainly into various structures of the CNS (according to autopsies – in about 20 % of patients with glioblastomas), the probability of their metastases to other organs (so-called extraneural metastases), according to some evaluations, is quite rare and doesn’t exceed 2 %. In our practice since 1993, which counts 1700 children with malignant gliomas, including 830 patients with DMG, we’ve observed only one patient with extraneural metastases. The article describes this case of a child who died of the progression of the DMG’s extraneural metastases, despite the fact that chemoradiotherapy had achieved its stabilization in the CNS. This patient with the initial lesion of the pons and cerebellum had massive metastasis to the lymph nodes: supraclavicular, mediastinal, retroperitoneal and inguinal ones, as well as to both pleural cavities, which occurred about one year after treatment of the progression, which had manifested in the form of continued growth of the primary tumor and its dissemination in the central nervous system. The article provides literature data on the frequency, clinical manifestations and possible treatment approaches for extraneural metastasis of brain gliomas. Extraneural metastases of those tumors occur most often to the bones, lymphatic system, lungs, abdominal organs, soft tissues. The effective treatment for extraneural metastases of gliomas has not been developed yet, which makes it urgent to solve this problem through multicenter studies.

About the Authors

O. S. Regentova
Russian Scientific Center of Roentgen Radiology
Russian Federation

Olga S. Regentova – Cand. Sci. (Med.), MD, head of Pediatric Radiation Oncology Department with beds for oncology patients, Russian Scientific Center of Roentgenoradiology, Moscow, Russian Federation

ORCID: https://orcid.org/0000-0002-0219-7260, SPIN: 9657-0598, AuthorID: 1011228


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



R. A. Parkhomenko
Russian Scientific Center of Roentgen Radiology; RUDN Medical Institute
Russian Federation

Roman A. Parkhomenko – Dr. Sci. (Med.), MD, leading researcher at the Laboratory of Radiation Therapy and complex methods of cancer treatment, Russian Scientific Center of Roentgenoradiology, Moscow, Russian Federation; Professor of the Department of Oncology and Radiology, RUDN Medical Institute, Moscow, Russian Federation

ORCID: https://orcid.org/0000-0001-9249-9272, SPIN: 9902-4244, AuthorID: 702112, Scopus Author ID: 6603021483


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



O. I. Shcherbenko
Russian Scientific Center of Roentgen Radiology
Russian Federation

Oleg I. Shcherbenko – Dr. Sci. (Med.), MD, Chief scientific officer at the Laboratory of Radiation Therapy and complex methods of cancer treatment, Russian Scientific Center of Roentgenoradiology, Moscow, Russian Federation

ORCID: https://orcid.org/0000-0003-0786-5448, SPIN: 9818-9276, AuthorID: 485883


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



F. F. Antonenko
Russian Scientific Center of Roentgen Radiology
Russian Federation

Fedor F. Antonenko – Dr. Sci. (Med.), MD, Professor, corresponding member of RAS, Head of the Laboratory of Radiation Therapy and complex methods of cancer treatment, Russian Scientific Center of Roentgenoradiology, Moscow, Russian Federation

ORCID: https://orcid.org/0000-0001-5900-6755, SPIN: 6582-8081, AuthorID: 261007, Scopus Author ID: 6602615840


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



N. I. Zelinskaya
Russian Scientific Center of Roentgen Radiology
Russian Federation

Natalya I. Zelinskaya – Cand. Sci. (Med.), MD, senior researcher of the Laboratory of Radiation Therapy and complex methods of cancer treatment, Russian Scientific Center of Roentgenoradiology, Moscow, Russian Federation

ORCID: https://orcid.org/0009-0000-5380-2056, SPIN: 4092-4845, AuthorID: 123005


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



N. Sidibe
Russian Scientific Center of Roentgen Radiology
Russian Federation

Nelly Sidibe – Cand. Sci. (Med.), MD, radiation oncologist of pediatric radiation oncology department with oncology sickbeds, Russian Scientific Center of Roentgenoradiology, Moscow, Russian Federation

ORCID: https://orcid.org/0000-0002-5556-0166, SPIN: 3660-6207, AuthorID: 1108540


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



P. V. Polushkin
Russian Scientific Center of Roentgen Radiology
Russian Federation

Pavel V. Polushkin – Cand. Sci. (Med.), MD, researcher of the Laboratory of Radiation Therapy and complex methods of cancer treatment, radiation oncologist of pediatric radiation oncology department with oncology sickbeds, Russian Scientific Center of Roentgenoradiology, Moscow, Russian Federation

ORCID: https://orcid.org/0000-0001-6661-0280, SPIN: 7600-7304, AuthorID: 1099115


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



A. I. Shevtsov
Russian Scientific Center of Roentgen Radiology
Russian Federation

Andrey I. Shevtsov – Cand. Sci. (Med.), MD, radiation oncologist of pediatric radiation oncology department with oncology sickbeds, Russian Scientific Center of Roentgenoradiology, Moscow, Russian Federation

ORCID: https://orcid.org/0000-0002-4539-5187, SPIN: 5605-6768, AuthorID: 996411


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



M. A. Bliznichenko
Russian Scientific Center of Roentgen Radiology
Russian Federation

Maria A. Bliznichenko – MD, clinical resident doctor of Pediatric Radiation Oncology Department with beds for oncology patients, Russian Scientific Center of Roentgenoradiology, Moscow, Russian Federation

ORCID: https://orcid.org/0009-0007-4300-5759


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



V. A. Deyanova
Russian Scientific Center of Roentgen Radiology
Russian Federation

Valeria A. Deyanova – MD, clinical resident doctor of Pediatric Radiation Oncology Department with beds for oncology patients, Russian Scientific Center of Roentgenoradiology, Moscow, Russian Federation

ORCID: https://orcid.org/0009-0001-1203-2195


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



V. A. Solodkiy
Russian Scientific Center of Roentgen Radiology
Russian Federation

Vladimir A. Solodkiy – Dr. Sci. (Med.), MD, Professor, Academician of RAS, Director, Russian Scientific Center of Roentgen Radiology, Moscow, Russian Federation

ORCID: https://orcid.org/0000-0002-1641-6452, SPIN: 9556-6556, AuthorID: 440543, ResearcherID: T-6803-2017, Scopus Author ID: 57193878871


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



References

1. Lu VM, Alvi MA, McDonald KL, Daniels DJ. Impact of the H3K27M mutation on survival in pediatric high-grade glioma: a systematic review and meta-analysis. J Neurosurg Pediatr. 2018 Nov 30;23(3):308-316. doi: 10.3171/2018.9.PEDS18419. https://pubmed.ncbi.nlm.nih.gov/30544362/

2. Wang Y, Feng LL, Ji PG, Liu JH, Guo SC, Zhai YL et al. Clinical Features and Molecular Markers on Diffuse Midline Gliomas With H3K27M Mutations: A 43 Cases Retrospective Cohort Study. Front Oncol. 2021 Feb 15;10:602553. doi: 10.3389/fonc.2020.602553. https://pubmed.ncbi.nlm.nih.gov/33659209/

3. Navarro RE, Golub D, Hill T, McQuinn MW, William C, Zagzag D et al. Pediatric midline H3K27M-mutant tumor with disseminated leptomeningeal disease and glioneuronal features: case report and literature review. Childs Nerv Syst. 2021 Jul;37(7):2347-2356. doi: 10.1007/s00381-020-04892-0. Epub 2020 Sep 28. https://pubmed.ncbi.nlm.nih.gov/32989496/

4. Ge X, Yang Y, Wang W, Tian L, Zhang G, Tian Z, Xue X. Pediatric H3K27M‑mutant diffuse midline glioma with vertebral metastasis: A case report and literature review. Oncol Lett. 2023 Dec 7;27(2):48. doi: 10.3892/ol.2023.14181. https://pubmed.ncbi.nlm.nih.gov/38192660/

5. Beauchesne P. Extra-neural metastases of malignant gliomas: myth or reality? Cancers (Basel). 2011 Jan 27;3(1):461-77. doi:10.3390/cancers3010461.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756372/

6. Hamilton JD, Rapp M, Schneiderhan T, Sabel M, Hayman A, Scherer A et al. Glioblastoma multiforme metastasis outside the CNS: three case reports and possible mechanisms of escape. J Clin Oncol. 2014 Aug 1;32(22):e80-4. doi: 10.1200/JCO.2013.48.7546. Epub 2014 Feb 24. Erratum in: J Clin Oncol. 2014 Oct 20;32(30):3462. https://pubmed.ncbi.nlm.nih.gov/24567434/

7. Davis L. Spongioblastoma multiforme of the brain. Ann Surg. 1928 Jan;87(1):8-14. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1398388/pdf/annsurg00602-0014.pdf

8. Pietschmann S, von Bueren AO, Henke G, Kerber MJ, Kortmann RD, Müller K. An individual patient data meta-analysis on characteristics, treatments and outcomes of the glioblastoma/gliosarcoma patients with central nervous system metastases reported in literature until 2013. J Neurooncol. 2014 Dec;120(3):451-7. doi: 10.1007/s11060-014-1596-x. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393116/

9. De Martino L, Picariello S, Russo C, Errico ME, Spennato P, Papa MR et al. Extra-neural metastases in pediatric diffuse midline gliomas, H3 K27-altered: presentation of two cases and literature review. Front Mol Neurosci. 2023 Jul 20;16:1152430. doi: 10.3389/fnmol.2023.1152430.. https://pubmed.ncbi.nlm.nih.gov/37547920/

10. Stephens S, Tollesson G, Robertson T, Campbell R. Diffuse midline glioma metastasis to the peritoneal cavity via ventriculo-peritoneal shunt: Case report and review of literature. J Clin Neurosci. 2019 Sep;67:288-293. doi: 10.1016/j.jocn.2019.06.043. Epub 2019 Jun 29. PMID: 31266714.

11. Jimsheleishvili S, Alshareef AT, Papadimitriou K, Bregy A, Shah AH, Graham RM et al. Extracranial glioblastoma in transplant recipients. J Cancer Res Clin Oncol. 2014 May;140(5):801-7. doi: 10.1007/s00432-014 16253.https://pubmed.ncbi.nlm.nih.gov/24595597/

12. Nauen DW, Li QK. Cytological diagnosis of metastatic glioblastoma in the pleural effusion of a lung transplant patient. Diagn Cytopathol. 2014 Jul;42(7):619-23. doi: 10.1002/dc.22993. https://pubmed.ncbi.nlm.nih.gov/23554289/

13. Yang G, Fang Y, Zhou M, Li W, Dong D, Chen J et al. Case report: The effective response to pembrolizumab in combination with bevacizumab in the treatment of a recurrent glioblastoma with multiple extracranial metastases. Front Oncol. 2022 Aug 16;12:948933. doi: 10.3389/fonc.2022.948933. https://pubmed.ncbi.nlm.nih.gov/36052225/

14. Noch EK, Sait SF, Farooq S, Trippett TM, Miller AM. A case series of extraneural metastatic glioblastoma at Memorial Sloan Kettering Cancer Center. Neurooncol Pract. 2021 Feb 3;8(3):325-336. doi: 10.1093/nop/npaa083. https://pubmed.ncbi.nlm.nih.gov/34055380/

15. Undabeitia J, Castle M, Arrazola M, Pendleton C, Ruiz I, Úrculo E. Multiple extraneural metastasis of glioblastoma multiforme. An Sist Sanit Navar. 2015 Jan-Apr;38(1):157-61. doi: 10.23938/ASSN.0061.

16. Kim AV, Hachatryan VA, Samochernyh KA, Zabrodskaya YU M. Ekstranevral'noe metastazirovanie glioblastomy. Grekov's Bulletin of Surgery., - 2007 - 166 (6), s. 70-74 (In Russian)https://cyberleninka.ru/article/n/ekstranevralnoe-metastazirovanie-glioblastomy

17. Razmologova O YU, Sokolova T V. A rare case of glioblastoma metastasis to the lung. Russian Journal of Archive of Pathology. 2013;75(4):34-36 ( in Russian)https://www.mediasphera.ru/issues/arkhiv-patologii/2020/4/1000419552013041034

18. ZHetpisbaev B, Isahanova B. Metastaz glioblastomy v legkoe // ZHurn. Medicina. – 2015. – №5 (155). – S. 29 31 ( In Russian) https://www.medzdrav.kz/images/magazine/medecine/2015/2015-5/M_05-15-01_29-31.pdf


Review

For citations:


Regentova O.S., Parkhomenko R.A., Shcherbenko O.I., Antonenko F.F., Zelinskaya N.I., Sidibe N., Polushkin P.V., Shevtsov A.I., Bliznichenko M.A., Deyanova V.A., Solodkiy V.A. Extraneural metastases of a cerebral glioma in a child: case report with literature review. South Russian Journal of Cancer. 2024;5(3):111-120. https://doi.org/10.37748/2686-9039-2024-5-3-10. EDN: PFVHLB

Views: 372


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2686-9039 (Online)